Poland's Polityka Lekowa 2.0 aims to boost pharma investment competitiveness

Polish commentary argues that Polityka Lekowa 2.0, a drug policy initiative, could attract pharmaceutical investments but requires whole-of-government coordination and broader economic competitiveness focus. The piece is an opinion, not a policy announcement, and its impact depends on government adoption.